JPRN-UMIN000024707已完成未知
The study of the response to the chemotherapy using S-1 and CDGP for p16 positive/p53 negative oropharnygeal squamous cell carcinoma - Chemotherapy for P16+/p53- OPSCC
Kobe City Medical Center General Hospital, Head and Neck Department0 个研究点目标入组 50 人开始时间: 2016年12月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •The patients with any distant metastasis The patients who are pregnant or possibly pregnant The patients who have a history of surgery or radiation in the oropharynx The patients whose general conditions are too poor for chemotherapy The patients with some conditions which may disturb safety transoral surgery, such as under strong anticoagulants, with severe trismus and so on The patients who are judged to be inappropriate for the study
研究者
相似试验
已完成
不适用
Treatment response of chemotherapy in patient with lung cancer:evaluation of tumor blood flow using H215O-PET/CTlung cancerJPRN-UMIN000021847Osaka University Graduate School of Medicine30
已完成
不适用
A prospective study of the effect of chemotherapy on metabolic and cardiovascular function in women with early stage breast cancerEarly stage breast cancerCancer - BreastACTRN12614001055695A/Prof Bogda Koczwara29
撤回
不适用
Control of emesis in R-CHOP (Rituximab (R) - Cyclophosphamide (C), Doxorubicin (H), Vincristine (O), Prednisolone (P)ACTRN12611001269921Australasian Leukaemia and Lymphoma Group100
进行中（未招募）
不适用
Observational study in Breast cancer patient who are taking Anthracyclin Chemotherapy to observe chemotherapy induced nausea and vomitingCTRI/2016/01/006555Tata Memorial Centre
尚未招募
Unknown
Observational study of chemotherapy for unresectable intrahepatic cholangiocarcinomantrahepatic cholangiocarcinomaJPRN-UMIN000053251Kumamoto university60